Miracit 7.5 mg/5 ml (Syrup)
Medicine Details
Category | Details |
---|---|
Generic | Butamirate citrate |
Company | Aristopharma ltd |
Indications
Relieves dry cough, pre & post-operative sedation, acute cough of any etiology, whooping cough, cough due to acute lower respiratory tract infections
Pharmacology
Acts on the brain's cough center, safe and non-sedating, rapidly absorbed, protein-bound, plasma half-life of 13 hours, active metabolites have antitussive action
Dosage & Administration
- Adult:
- Butamirate Citrate 50 mg tablet: 2-3 tablets daily
- Butamirate Citrate syrup: 15 ml 4 times daily
- Children & Adolescents:
- Tablet: Adolescent over 12 years old: 1-2 tablets daily
- Syrup:
- Children (3-6 yrs): 5 ml 3 times daily
- Children (6-12 yrs): 10 ml 3 times daily
- Adolescent: 15 ml 3 times daily
- Pediatric Drops:
- Children (2 months-1 yr): 0.50 ml 4 times daily
- Children (1-3 yrs): 0.75 ml 4 times daily
Interaction
Concomitant use with expectorants should be avoided
Contraindications
Hypersensitivity to the active ingredient
Side Effects
- Good tolerance
- Adverse reactions: rash, nausea, diarrhea, vertigo (rare cases)
Pregnancy & Lactation
Avoid use during first trimester, cautious use in later pregnancy, carefully weigh benefits against risks during breastfeeding
Precautions & Warnings
Avoid concomitant use with expectorants, consult doctor if cough persists for more than 7 days (3 days in children <12 years)
Overdose Effects
Symptoms: drowsiness, nausea, vomiting, diarrhea, loss of balance, hypotension; follow standard emergency procedures
Therapeutic Class
Cough suppressant
Storage Conditions
Keep away from light and moisture, store below 30°C, keep out of reach of children
Related Brands
- Bucod SR 50 mg (Tablet (Sustained Release)) - sharif-pharmaceuticals-ltd
- Bukof 50 mg (Tablet (Sustained Release)) - beacon-pharmaceuticals-plc
- Deconil SR 50 mg (Tablet (Sustained Release)) - orion-pharma-ltd
- Kofnix SR 50 mg (Tablet (Sustained Release)) - aci-limited
- Mirakof SR 50 mg (Tablet (Sustained Release)) - square-pharmaceuticals-plc